Net Cash Provided by (Used in) Operating Activities |
-19.1M |
USD |
-49.8% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
116M |
USD |
-42.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-56M |
USD |
+60.1% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q4 2024 |
FY 2024 |
Common Stock, Shares, Issued |
49.8M |
shares |
+21.1% |
Q4 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
41.1M |
USD |
-18.7% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
114M |
USD |
+131% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
79.9M |
USD |
+154% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
79.9M |
USD |
+154% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
15.6M |
USD |
+97.5% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
4.51M |
USD |
+319% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
494M |
USD |
+35% |
Q4 2024 |
FY 2024 |
Depreciation, Depletion and Amortization |
8K |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
11.3M |
USD |
+124% |
Q4 2024 |
FY 2024 |